Back

Optimal ways to identify high-risk cohorts beyond low-density lipoproteins: unmet high-risk patients

31 August 2026 (08:15 - 08:33)
Organised by: Logo
Congress Presentation Part of: Assessing and treating 'residual risk' beyond low-density lipoproteins Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

4 More presentations in this session

Presentation thumbnail
Targeting lipoprotein(a)
Professor B. Nordestgaard (Copenhagen, DK)
Slides Video
Presentation thumbnail
Colchicine: who benefits?
Doctor J. Tardif (Montreal, CA)
Slides Video
Presentation thumbnail
GLP1 agonist: for everyone?
Professor E. Michos (Baltimore, US)
Slides Video
Presentation thumbnail
Assessing and treating 'residual risk' beyond low-density lipoproteins - discussion
Video

Access the full session

Session thumbnail
Assessing and treating 'residual risk' beyond low-density lipoproteins
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Inflammation as a therapeutic target in atherosclerosis: what do we know about residual inflammation and available treatments?
28 August 2026
thumbnail
Congress Presentation
Genetics and imaging for risk prediction: when does it really help? - discussion
25 April 2026
thumbnail
Congress Presentation
Prevalence of clinically actionable hsCRP and implications for statin eligibility and residual ASCVD risk in the United States
30 August 2026
thumbnail
Congress Session
Secondary prevention: biomarkers to optimise outcomes
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources